Single-implant Overdentures Retained by the Novaloc Attachment System
Launched by MCGILL UNIVERSITY · Apr 24, 2017
Trial Information
Current as of April 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Not have had a tooth extraction within the past six months
- • Request implant stabilization of a mandibular conventional complete denture
- • Have clinically acceptable maxillary and mandibular complete dentures
- • Have adequate bone in the anterior mandible for the placement of a single 3.3 mm wide implant in the midline
- • Be able to maintain adequate oral hygiene and clean dentures;
- • Present no systemic conditions for which minor oral surgery would be counter-indicated
- • Have an adequate understanding of written and spoken English or French;
- • Be capable of giving written informed consent
- Exclusion Criteria:
- • Severe/serious illness that requires frequent hospitalization
- • Impaired cognitive function
- • Unable to return for evaluations/study recalls
- • Have a history of radiation therapy to the orofacial region
- • Have specific conditions that may jeopardize the treatment, such as alcoholism or smoking (\>10 cigarettes/day)
- • Have acute or chronic symptoms of parafunctional or temporomandibular disorders
- • Previous dental implant treatment
- • Following radiographic exam, investigators will exclude volunteers with bony pathologic lesions, less than 11 mm of minimum vertical mandibular bone height in the midline or width for planned implants, evident endosseous vascular structures or mandibular ridges with remaining alveolar sockets
About Mcgill University
McGill University, a prestigious research institution located in Montreal, Canada, is committed to advancing medical science through innovative clinical trials. Renowned for its rigorous academic standards and collaborative approach, McGill fosters a dynamic environment that integrates cutting-edge research with clinical practice. With a focus on improving patient outcomes, the university's clinical trials span a wide range of therapeutic areas, leveraging the expertise of its diverse faculty and state-of-the-art facilities. McGill University is dedicated to ethical research practices and the dissemination of knowledge, ensuring that findings contribute meaningfully to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Montreal, Quebec, Canada
Patients applied
Trial Officials
Raphael F de Souza
Principal Investigator
McGill University, Faculty of Dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials